StockData
Sionna Therapeutics, Inc. logo

Sionna Therapeutics, Inc. (SION) stock

SIONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$2.83−0.15 (-4.88%)

Close on Nov 20, 2026Market cap $127.73MP/E –Yield –

Sionna Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Sionna Therapeutics's shares outstanding was 45M at Sep 30, 2026. For fiscal 2025 it was 40M, up 935.6% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202540M+935.6%
FY2024Dec 31, 20244M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 202645M+2.2%
Q2 FY2026Jun 30, 202645M+2.3%
Q1 FY2026Mar 31, 202645M+68.9%
Q4 FY2025Dec 31, 202545M+851.3%
Q3 FY2025Sep 30, 202544M+886.6%
Q2 FY2025Jun 30, 202544M+1296.2%
Q1 FY2025Mar 31, 202527M+762.8%
Q4 FY2024Dec 31, 20245M–
Q3 FY2024Sep 30, 20244M–
Q2 FY2024Jun 30, 20243M–
Q1 FY2024Mar 31, 20243M–

More Sionna Therapeutics figures

See a number that looks wrong?